Stocktoria
Crinetics Pharmaceuticals, Inc. CRNX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-07-18
Chart by TradingView
2/9
Piotroski F — financial health
6.19
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$3.9B
P / B3.9×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $7.7M | $1.0M | $4.0M | $4.7M | $1.1M |
| Operating income | -$516.8M | -$338.9M | -$222.6M | -$167.9M | -$107.7M |
| Net income | -$465.3M | -$298.4M | -$214.5M | -$163.9M | -$107.6M |
| Operating cash flow | -$377.9M | -$230.2M | -$168.6M | -$115.2M | -$88.6M |
| Free cash flow | -$383.7M | -$234.0M | -$173.3M | -$116.9M | -$89.0M |
| Total assets | $1.1B | $1.4B | $635.4M | $352.2M | $351.0M |
| Total liabilities | $134.2M | $109.8M | $96.2M | $35.8M | $19.1M |
| Shareholders' equity | $992.1M | $1.3B | $539.1M | $316.3M | $331.9M |
| Ratios | |||||
| Operating margin | -6714.8% | -32613.5% | -5547.2% | -3544.1% | -9990.9% |
| Net margin | -6046.2% | -28720.7% | -5345.9% | -3460.4% | -9985.3% |
| FCF margin | -4985.5% | -22525.3% | -4318.1% | -2467.0% | -8258.3% |
| Return on assets | -41.3% | -20.8% | -33.8% | -46.5% | -30.7% |
| Return on equity | -46.9% | -22.5% | -39.8% | -51.8% | -32.4% |
| Current ratio | 12.32 | 23.04 | 13.07 | 12.45 | 21.55 |
| Revenue growth | 640.7% | -74.1% | -15.3% | 339.4% | 1418.3% |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6.19 (safe)
- Working capital / assets 0.855
- Retained earnings / assets -1.259
- EBIT / assets -0.459
- Equity / liabilities 7.394
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001658247 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.